Dexmedetomidine sedation reduces the incidence of atrial fibrillation in mechanically ventilated patients with COVID-19 pneumonia: A randomized controlled trial

References

• Orellana JDY, de Souza MLP. Excess suicides in Brazil: inequalities according to age groups and regions during the COVID-19 pandemic. Int J Soc Psychiatry. 2022;68(5):207640221097826.
   Web of Science ®Google Scholar
• Seecheran R, Narayansingh R, Giddings S, et al. Atrial Arrhythmias in a patient presenting with coronavirus disease-2019 (COVID-19) Infection. J Investig Med High Impact Case Rep. 2020;8:2324709620925571.
   Web of Science ®Google Scholar
• Guzik TJ, Mohiddin SA, Dimarco A, et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovasc Res. 2020;116(10):1666–1687. DOI:10.1093/cvr/cvaa106
   PubMed Web of Science ®Google Scholar
• Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID-19 and cardiac disease in Northern Italy. Eur Heart J. 2020;41(19):1821–1829. DOI:10.1093/eurheartj/ehaa388
   PubMed Web of Science ®Google Scholar
• Gopinathannair R, Merchant FM, Lakkireddy DR, et al. COVID-19 and cardiac arrhythmias: a global perspective on arrhythmia characteristics and management strategies. J Interv Card Electrophysiol. 2020;59(2):329–336. DOI:10.1007/s10840-020-00789-9
   PubMed Web of Science ®Google Scholar
• Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients with 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI:10.1001/jama.2020.1585
   PubMed Web of Science ®Google Scholar
• Gawałko M, Kapłon-Cieślicka A, Hohl M, et al. COVID-19 associated atrial fibrillation: incidence, putative mechanisms and potential clinical implications. Int J Cardiol Heart Vasc. 2020;30:100631.
   PubMed Web of Science ®Google Scholar
• Hu YF, Cheng WH, Hung Y, et al. Management of Atrial Fibrillation in COVID-19 Pandemic. Circ J. 2020;84(10):1679–1685. DOI:10.1253/circj.CJ-20-0566
   PubMed Web of Science ®Google Scholar
• Stone E, Kiat H, McLachlan CS. Atrial fibrillation in COVID-19: a review of possible mechanisms. Faseb J. 2020;34(9):11347–11354.
   PubMed Web of Science ®Google Scholar
• Zhao H, Davies R, Ma D. Potential therapeutic value of dexmedetomidine in COVID-19 patients admitted to ICU. Br J Anaesth. 2021;126(1):e33–5.
   PubMed Web of Science ®Google Scholar
• Riker RR, Shehabi Y, Bokesch PM, et al. Dexmedetomidine vs Midazolam for Sedation of Critically Ill Patients: a Randomized Trial. JAMA. 2009;301(5):489–499. DOI:10.1001/jama.2009.56
   PubMed Web of Science ®Google Scholar
• Lewis K, Alshamsi F, Carayannopoulos KL, et al. Dexmedetomidine vs other sedatives in critically ill mechanically ventilated adults: a systematic review and meta-analysis of randomized trials. Intensive care Med. 2022;48(7):811–840. DOI:10.1007/s00134-022-06712-2
   PubMed Web of Science ®Google Scholar
• Azeem TMA, Yosif NE, Alansary AM, et al. Dexmedetomidine vs morphine and midazolam in the prevention and treatment of delirium after adult cardiac surgery; a randomized, double-blinded clinical trial. Saudi J Anaesth. 2018;12(2):190–197.
   PubMed Web of Science ®Google Scholar
• Talib U, Ahmad I. Dexmedetomidine-associated bradycardia: a blessing in disguise for management of atrial tachyarrythmias in patients with COVID-19 requiring sedation. Chest. 2020;158(4):A417.
   Web of Science ®Google Scholar
• Liu X, Zhang K, Wang W, et al. Dexmedetomidine sedation reduces atrial fibrillation after cardiac surgery compared to propofol: a randomized controlled trial. crit care. 2016;20(1):298.
   PubMedGoogle Scholar
• Turan A, Bashour CA, You J, et al. Dexmedetomidine sedation after cardiac surgery decreases atrial arrhythmias. J Clin Anesth. 2014;26(8):634–642. DOI:10.1016/j.jclinane.2014.05.009
   PubMed Web of Science ®Google Scholar
• Narisawa A, Nakane M, Kano T, et al. Dexmedetomidine sedation during the nighttime reduced the incidence of postoperative atrial fibrillation in cardiovascular surgery patients after tracheal extubation. J Intensive Care. 2015;3(1):26. DOI:10.1186/s40560-015-0092-5
   PubMedGoogle Scholar
• Steinberg JS, O’Connell H, Li S, et al. Thirty-second gold standard definition of atrial fibrillation and its relationship with subsequent arrhythmia patterns: analysis of a large prospective device database. Circ Arrhythm Electrophysiol. 2018;11(7):e006274.
   PubMed Web of Science ®Google Scholar
• Hindricks G, Potpara T, Dagres N, et al. ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2020;2021(42):373–498.
   Google Scholar
• Weerink MAS, Struys M, Hannivoort LN, et al. Clin Pharmacokinet and Pharmacodynamics of Dexmedetomidine. Clin Pharmacokinet. 2017;56(8):893–913.
   PubMed Web of Science ®Google Scholar
• Afonso J, Reis F. Dexmedetomidine: current role in anesthesia and intensive care. Rev Bras Anestesiol. 2012;62(1):118–133.
   PubMed Web of Science ®Google Scholar
• Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015;115(2):171–182.
   PubMed Web of Science ®Google Scholar
• Chrysostomou C, Beerman L, Shiderly D, et al. Dexmedetomidine: a novel drug for the treatment of atrial and junctional tachyarrhythmias during the perioperative period for congenital cardiac surgery: a preliminary study. Anesth Analg. 2008;107(5):1514–1522.
   PubMed Web of Science ®Google Scholar
• Chrysostomou C, Morell VO, Wearden P, et al. Dexmedetomidine: therapeutic use for the termination of reentrant supraventricular tachycardia. Congenit Heart Dis. 2013;8(1):48–56.
   PubMed Web of Science ®Google Scholar
• Ambrus DB, Benjamin EJ, Bajwa EK, et al. Risk factors and outcomes associated with new-onset atrial fibrillation during acute respiratory distress syndrome. J Crit Care. 2015;30(5):994–997.
   PubMed Web of Science ®Google Scholar
• Klein Klouwenberg PM, Frencken JF, Kuipers S, et al. Incidence, predictors, and outcomes of new-onset atrial fibrillation in critically ill patients with sepsis. A cohort study. Am J Respir Crit Care Med. 2017;195(2):205–211. DOI:10.1164/rccm.201603-0618OC
   PubMed Web of Science ®Google Scholar
• Walkey AJ, Hammill BG, Curtis LH, et al. Long-term outcomes following development of new-onset atrial fibrillation during sepsis. Chest. 2014;146(5):1187–1195.
   PubMed Web of Science ®Google Scholar
• Kanthasamy V, JS R. Incidence and prognostic impact of new-onset atrial fibrillation in patients with severe Covid-19: a Retrospective Cohort Study. J Atr Fibrillation. 2021;14(2):14.
   Google Scholar
• Ergün B, Ergan B, Sözmen MK, et al. New-onset atrial fibrillation in critically ill patients with coronavirus disease 2019 (COVID-19). J Arrhythm. 2021;37(5):1196–1204. DOI:10.1002/joa3.12619
   PubMed Web of Science ®Google Scholar
• Ji F, Li Z, Nguyen H, et al. Perioperative dexmedetomidine improves outcomes of cardiac surgery. Circulation. 2013;127(15):1576–1584. DOI:10.1161/CIRCULATIONAHA.112.000936
   PubMed Web of Science ®Google Scholar
• Ren J, Zhang H, Huang L, et al. Protective effect of dexmedetomidine in coronary artery bypass grafting surgery. Exp Ther Med. 2013;6(2):497–502.
   PubMed Web of Science ®Google Scholar
• Hu YF, Chen YJ, Lin YJ, et al. Inflammation and the pathogenesis of atrial fibrillation. Nat Rev Cardiol. 2015;12(4):230–243.
   PubMed Web of Science ®Google Scholar
• Stephens RS, Whitman GJ. Postoperative critical care of the adult cardiac surgical patient. part I: routine postoperative care. Crit Care Med. 2015;43(7):1477–1497.
   PubMed Web of Science ®Google Scholar
• Neema PK. Dexmedetomidine in pediatric cardiac anesthesia. Ann Card Anaesth. 2012;15(3):177–179.
   PubMedGoogle Scholar
• Shingu Y, Kubota S, Wakasa S, et al. Postoperative atrial fibrillation: mechanism, prevention, and future perspective. Surg Today. 2012;42(9):819–824.
   PubMed Web of Science ®Google Scholar
• Wu C, Chen X, Cai Y, et al. Risk Factors Associated with Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934–943. DOI:10.1001/jamainternmed.2020.0994
   PubMed Web of Science ®Google Scholar
• Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475–481. DOI:10.1016/S2213-2600(20)30079-5
   PubMed Web of Science ®Google Scholar
• Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI:10.1016/S0140-6736(20)30183-5
   PubMed Web of Science ®Google Scholar
• Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in Critically Ill Patients in the Seattle Region — Case Series. N Engl J Med. 2020;382(21):2012–2022. DOI:10.1056/NEJMoa2004500
   PubMed Web of Science ®Google Scholar
• Arentz M, Yim E, Klaff L, et al. Characteristics and Outcomes of 21 Critically Ill Patients with COVID-19 in Washington State. JAMA. 2020;323(16):1612–1614. DOI:10.1001/jama.2020.4326
   PubMed Web of Science ®Google Scholar